Zhao, Dan
Zhou, Fang
Liu, Weixin
Huang, Zhou
Xu, Xiaolong
Zheng, Baomin
Liu, Changqing
Bai, Chujie
Liu, Jiayong
Sun, Yan
Wang, Weihu
Xiao, Shaowen
Funding for this research was provided by:
Beijing Hospital Authority Ascent Plan (DFL20220902)
Article History
Received: 15 September 2023
Accepted: 4 March 2024
First Online: 14 March 2024
Declarations
:
: The study protocol was approved by the ethics committee of the Beijing Cancer Hospital and Institute, Peking University School of Oncology (approval number: 2023YJZ87) and individual informed consent for this study was waived for this retrospective analysis. But all patients provided written informed consent for the treatment they received. All procedures were conducted in accordance with the principles outlined in the Declaration of Helsinki.
: Not Applicable.
: The authors declare no competing interests.